There are lots of treatment options for genetic COPD (chronic obstructive pulmonary disease), a type of COPD caused by a deficiency of alpha-1 antitrypsin (alpha-1), a protein that helps protect the ...

Researchers examined the medical costs for patients with a rare subset of chronic obstructive pulmonary disease (COPD) caused by a deficiency in alpha-1 antitrypsin receiving augmentation therapy.

Alpha-1 antitrypsin deficiency, or AATD, is an inherited disease that affects the lung, liver, and skin. The current treatment landscape involves smoking cessation, COPD treatment, and augmentation ...

Professor Gerry McElvaney, Professor of Medicine, RCSI University of Medicine and Health Sciences and senior co-author of a new study, published in the American Journal of Respiratory and Critical ...

Boosting levels of a deficient protein has clear survival benefits for people with the genetic condition alpha-1 antitrypsin deficiency (AATD), according to new research led by RCSI University of ...